ASP Isotopes (ASPI) Common Equity (2021 - 2026)

ASP Isotopes' Common Equity history runs 6 years deep, the most recent figure standing at $289.0 million for Q1 2026.

• In Q1 2026, Common Equity rose 531.99% year-over-year to $289.0 million; the TTM figure through Mar 2026 stood at $289.0 million (up 531.99% YoY), while the FY2025 annual figure was $262.9 million, up 413.8% from the prior year.
• Common Equity for Q1 2026 stood at $289.0 million, up from $262.9 million in the prior quarter.
• The five-year high for Common Equity was $289.0 million in Q1 2026, with the low at $6.3 million in Q3 2022.
• The 5-year median for Common Equity is $14.4 million (2024), against an average of $53.0 million.
• The sharpest annual moves came in 2024 and 2026: Common Equity gained 9.36% in 2024, then surged 531.99% in 2026.
• ASP Isotopes' Common Equity stood at $9.8 million in 2022, then jumped by 91.81% to $18.8 million in 2023, then soared by 171.72% to $51.2 million in 2024, then soared by 413.8% to $262.9 million in 2025, then advanced by 9.93% to $289.0 million in 2026.
• Business Quant data shows ASPI's Common Equity at $289.0 million in Q1 2026, $262.9 million in Q4 2025, and $74.1 million in Q3 2025.